Moneycontrol
HomeNewsIndiaCOVID ebbing as R-value drops to below 1 in country, including Kerala and NE: Study

COVID ebbing as R-value drops to below 1 in country, including Kerala and NE: Study

The R-value of Kerala, which has the highest number of active cases in the country, is now below 1 after a gap of seven months, signalling a relief to authorities who have been struggling to bring down the injection levels in the state.

August 18, 2021 / 18:04 IST
Story continues below Advertisement
(Representative image)

After breaching the value of 1 in the first week of August, the R number, which reflects how rapidly the coronavirus pandemic is spreading, has been steadily ebbing, according to researchers at the Institute of Mathematical Sciences, Chennai. India's R has fallen to around 0.9, Sitbara Sinha, who is leading the research, told PTI, citing their data.

If R is lesser than 1, it means the number of newly infected people is lower than the number of infected people in the preceding period and the disease incidence is going down.

Story continues below Advertisement

The R-value of Kerala, which has the highest number of active cases in the country, is now below 1 after a gap of seven months, signalling a relief to authorities who have been struggling to bring down the injection levels in the state.

The northeastern states seem to have finally come out of the second wave, Sinha said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show